Vitamin C in the treatment and/or prevention of obesity

Journal of Nutritional Science and Vitaminology

Volumn 60, Issue 6, 2014, Pages 367-379

  Garcia Diaz, Diego Fernando ^a   Lopez Legarrea, Patricia ^b   Quintero, Pablo ^c   Martinez, Jose Alfredo ^d,e  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSITY OF NAVARRA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antioxidant; Ascorbic acid; Body weight; Oxidative stress

Indexed keywords

ASCORBIC ACID; GLUCOCORTICOID; LEPTIN; ANTIOXIDANT; VITAMIN;

ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; GALLBLADDER DISEASE; GLUCOSE METABOLISM; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOXIA; INFLAMMATION; LIPID STORAGE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; REVIEW; VITAMIN INTAKE; ADIPOCYTE; ADRENAL GLAND; ANIMAL; DRUG EFFECTS; METABOLISM;

ANIMALIA;

ADIPOCYTES; ADRENAL GLANDS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; GLUCOCORTICOIDS; HUMANS; OBESITY; OXIDATIVE STRESS; VITAMINS;

EID: 84926395616     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.60.367     Document Type: Review

References (115)

1. Powers KA, Rehrig ST, Jones DB. 2007. Financial impact of obesity and bariatric surgery. Med Clin N Am 91: 321-338, ix.
2. Jarolimova J, Tagoni J, Stern TA. 2013. Obesity: its epidemiology, comorbidities, and management. Prim Care Companion CNS Disord 15(5). http://www.ncbi.nlm. nih.gov/pmc/articles/PMC3907314/.
3. Bray GA. 2004. Medical consequences of obesity. J Clin Endocrinol Metab 89: 2583-2589.
4. Griera L, Manzanares M, Barbany M, Contreras J, Amigo P, Salas-Salvado J. 2007. Physical activity, energy balance and obesity. Public Health Nutr 10: 1194-1199.
5. Low S, Chin MC, Deurenberg-Yap M. 2009. Review on epidemic of obesity. Ann Acad Med Singapore 38: 57-59.
6. Martinez JA. 2000. Body-weight regulation: causes of obesity. Proc Nutr Soc 59: 337-345.
7. Trayhurn P, Beattie JH. 2001. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339.
8. Zulet MA, Puchau B, Navarro C, Marti A, Martinez JA. 2007. Inflammatory biomarkers: the link between obesity and associated pathologies. Nutricion Hospitalaria 22: 511-527.
9. Martinez JA. 2006. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J Physiol Biochem 62: 303-306.
10. Ferrante AW Jr. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 262: 408-414.
11. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183-190.
12. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673- 1677.
13. Fantuzzi G. 2005. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-920.
14. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
15. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
16. Vincent HK, Taylor AG. 2006. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 30: 400-418.
17. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761.
18. Milagro FI, Campion J, Martinez JA. 2006. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 14: 1118-1123.
19. Mutlu-Turkoglu U, Oztezcan S, Telci A, Orhan Y, Aykac-Toker G, Sivas A, Uysal M. 2003. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2: 171-174.
20. Moreno-Aliaga MJ, Campión J, Milagro FI, Berjón A, Martínez JA. 2005. Adiposity and proinflammatory state: The chicken or the egg. Adipocytes 1: 1-9.
21. Lopez-Legarrea P, de la Iglesia R, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L, Martinez JA, Zulet MA. 2013. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr Metab (Lond) 10: 22.
22. Flora SJ. 2007. Role of free radicals and antioxidants in health and disease. Cell Mol Biol (Noisy-Le-Grand) 53: 1-2.
23. Li Y, Guo H, Wu M, Liu M. 2013. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China. Asia Pac J Clin Nutr 22: 60-68.
24. Bsoul SA, Terezhalmy GT. 2004. Vitamin C in health and disease. J Contemp Dent Pract 5: 1-13.
25. Campion J, Milagro FI, Fernandez D, Martinez JA. 2006. Differential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity. J Physiol Biochem 62: 71- 80.
26. Garcia-Diaz D, Campion J, Milagro FI, Martinez JA. 2007. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 305: 87-94.
27. Johnston CS, Beezhold BL, Mostow B, Swan PD. 2007. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr 137: 1757-1762.
28. Misekova D, Lincova D, Hynie S. 1993. The effect of ascorbic acid on adrenergic lipolysis. Sb Lek 94: 55-62.
29. Garcia-Diaz DF, Campion J, Milagro FI, Paternain L, Solomon A, Martinez JA. 2009. Ascorbic acid oral treatment modifies lipolytic response and behavioural activity but not glucocorticoid metabolism in cafeteria diet-fed rats. Acta Physiol (Oxf) 195: 449-457.
30. Hasegawa N, Niimi N, Odani F. 2002. Vitamin C is one of the lipolytic substances in green tea. Phytother Res 16 (Suppl 1): S91-92.
31. Senen D, Adanali G, Ayhan M, Gorgu M, Erdogan B. 2002. Contribution of vitamin C administration for increasing lipolysis. Aesthetic Plast Surg 26: 123-125.
32. Doulas NL, Constantopoulos A, Litsios B. 1987. Effect of ascorbic acid on guinea pig adrenal adenylate cyclase activity and plasma cortisol. J Nutr 117: 1108-1114.
33. Garcia-Diaz DF, Campion J, Milagro FI, Boque N, Moreno-Aliaga MJ, Martinez JA. 2010. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol Endocrinol 45: 33-43.
34. Abdel-Wahab YH, O'Harte FP, Mooney MH, Barnett CR, Flatt PR. 2002. Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism 51: 514-517.
35. Carcamo JM, Pedraza A, Borquez-Ojeda O, Golde DW. 2002. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 41: 12995-13002.
36. Garcia-Diaz DF, Campion J, Quintero P, Milagro FI, Moreno-Aliaga MJ, Martinez JA. 2011. Vitamin C modulates the interaction between adipocytes and macrophages. Mol Nutr Food Res 55 (Suppl 2): S257-263.
37. Arrigoni O, De Tullio MC. 2002. Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta 1569: 1-9.
38. Nishikimi M, Yagi K. 1991. Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54(6 Suppl): 1203S-1208S.
39. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. 1996. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93: 3704-3709.
40. Combs G. 2012. The Vitamins: Fundamental Aspects in Nutrition and HEALTH, 4th ed (Combs G, ed), p 598. Academic Press, New York.
41. Wilson JX. 2002. The physiological role of dehydroascorbic acid. FEBS Lett 527: 5-9.
42. Duarte TL, Lunec J. 2005. Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radic Res 39: 671-686.
43. Wilson JX. 2002. Bioavailability of oxidized vitamin C (dehydroascorbic acid). J Am Diet Assoc 102: 1222; author reply 1224-1225.
44. Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, Brubaker RF, Hediger MA. 1999. A family of mammalian Na1-dependent L-ascorbic acid transporters. Nature 399: 70-75.
45. Welch RW, Wang Y, Crossman A Jr, Park JB, Kirk KL, Levine M. 1995. Accumulation of vitamin C (ascorbate) and its oxidized metabolite dehydroascorbic acid occurs by separate mechanisms. J Biol Chem 270: 12584-12592.
46. Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I, Levine M. 1997. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem 272: 18982-18989.
47. Rivas CI, Zuniga FA, Salas-Burgos A, Mardones L, Ormazabal V, Vera JC. 2008. Vitamin C transporters. J Physiol Biochem 64: 357-375.
48. Valdecantos MP, Perez-Matute P, Martinez JA. 2009. Obesity and oxidative stress: role of antioxidant supplementation. Rev Invest Clin 61: 127-139.
49. Blakely S, Herbert A, Collins M, Jenkins M, Mitchell G, Grundel E, O'Neill KR, Khachik F. 2003. Lutein interacts with ascorbic acid more frequently than with alpha-tocopherol to alter biomarkers of oxidative stress in female zucker obese rats. J Nutr 133: 2838-2844.
50. Sorensen DI, Devine MM, Rivers JM. 1974. Catabolism and tissue levels of ascorbic acid following longterm massive doses in the guinea pig. J Nutr 104: 1041-1048.
51. Milagro FI, Campion J, Martinez JA. 2007. 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J Steroid Biochem Mol Biol 104: 81-84.
52. Campion J, Milagro FI, Fernandez D, Martinez JA. 2008. Vitamin C supplementation influences body fat mass and steroidogenesis-related genes when fed a high-fat diet. Int J Vitam Nutr Res 78: 87-95.
53. Berraondo B, Marti A, Duncan JS, Trayhurn P, Martinez JA. 2000. Up-regulation of muscle UCP2 gene expression by a new beta3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals. Int J Obes Relat Metab Disord 24: 156-163.
54. Lopez IP, Marti A, Milagro FI, Zulet MA, Moreno- Aliaga MJ, Martinez JA, De Miguel C. 2003. DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11: 188-194.
55. Campion J, Martinez JA. 2004. Ketoconazole, an antifungal agent, protects against adiposity induced by a cafeteria diet. Horm Metab Res 36: 485-491.
56. Del Rio D, Agnoli C, Pellegrini N, Krogh V, Brighenti F, Mazzeo T, Masala G, Bendinelli B, Berrino F, Sieri S, Tumino R, Rollo PC, Gallo V, Sacerdote C, Mattiello A, Chiodini P, Panico S. 2011. Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr 141: 118-123.
57. Johnston CS. 2005. Strategies for healthy weight loss: from vitamin C to the glycemic response. J Am Coll Nutr 24: 158-165.
58. Bahadoran Z, Golzarand M, Mirmiran P, Shiva N, Azizi F. 2012. Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond) 9: 70.
59. Canoy D, Wareham N, Welch A, Bingham S, Luben R, Day N, Khaw KT. 2005. Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study. Am J Clin Nutr 82: 1203-1209.
60. Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka T, Sivenius J, Salonen JT. 2002. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 33: 1568-1573.
61. Rendo-Urteaga T, Puchau B, Chueca M, Oyarzabal M, Azcona-Sanjulian MC, Martinez JA, Marti A. 2013. Total antioxidant capacity and oxidative stress after a 10-week dietary intervention program in obese children. Eur J Pediatr 173: 609-616.
62. Naylor GJ, Grant L, Smith C. 1985. A double blind placebo controlled trial of ascorbic acid in obesity. Nutr Health 4: 25-28.
63. Paolisso G, Balbi V, Volpe C, Varricchio G, Gambardella A, Saccomanno F, Ammendola S, Varricchio M, D'Onofrio F. 1995. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insu lin dependent diabetics. J Am Coll Nutr 14: 387-392.
64. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas I, Papademetriou L, Economou M, Stefanadis C. 2007. The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutr Metab Cardiovasc Dis 17: 590-597.
65. Martinez JA. 2006. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J Physiol Biochem 62: 303-306.
66. Garcia-Diaz DF, Campion J, Arellano AV, Milagro FI, Moreno-Aliaga MJ, Martinez JA. 2012. Fat intake leads to differential response of rat adipocytes to glucose, insulin and ascorbic acid. Exp Biol Med (Maywood) 237: 407-416.
67. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL. 2001. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 50: 159-165.
68. Vinayagamoorthi R, Bobby Z, Sridhar MG. 2008. Antioxidants preserve redox balance and inhibit c-Jun-Nterminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance. J Endocrinol 197: 287-296.
69. Codoner-Franch P, Lopez-Jaen AB, De La Mano-Hernandez A, Sentandreu E, Simo-Jorda R, Valls-Belles V. 2010. Oxidative markers in children with severe obesity following low-calorie diets supplemented with mandarin juice. Acta Paediatr 99: 1841-1846.
70. Hartwich J, Goralska J, Siedlecka D, Gruca A, Trzos M, Dembinska-Kiec A. 2007. Effect of supplementation with vitamin E and C on plasma hsCRP level and cobalt-albumin binding score as markers of plasma oxidative stress in obesity. Genes Nutr 2: 151-154.
71. Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, Taylor AW, Traber MG, Zimmermann MB. 2014. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J Nutr 144: 193-201.
72. Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P. 2008. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 45: 377-384.
73. Vincent HK, Taylor AG. 2006. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 30: 400-418.
74. Ono M, Aratani Y, Kitagawa I, Kitagawa Y. 1990. Ascorbic acid phosphate stimulates type IV collagen synthesis and accelerates adipose conversion of 3T3- L1 cells. Exp Cell Res 187: 309-314.
75. Krieger-Brauer HI, Kather H. 1995. Antagonistic effects of different members of the fibroblast and platelet- derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. Biochem J 307 (Pt 2): 549-556.
76. Kawada T, Aoki N, Kamei Y, Maeshige K, Nishiu S, Sugimoto E. 1990. Comparative investigation of vitamins and their analogues on terminal differentiation, from preadipocytes to adipocytes, of 3T3-L1 cells. Comp Biochem Physiol A Comp Physiol 96: 323-326.
77. Pintauro SJ, Bergan JG. 1982. Effects of ascorbic acid on in vitro steroidogenesis in guinea pigs. J Nutr 112: 584-591.
78. Pessler D, Rudich A, Bashan N. 2001. Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter. Diabetologia 44: 2156-2164.
79. Vera JC, Rivas CI, Fischbarg J, Golde DW. 1993. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364: 79-82.
80. Garcia-Diaz DF, Campion J, Quintero P, Milagro FI, Moreno-Aliaga MJ, Martinez JA. 2011. Vitamin C modulates the interaction between adipocytes and macrophages. Mol Nutr Food Res 55 (Suppl 2): S257-263.
81. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M. 1999. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406.
82. Stich V, Berlan M. 2004. Physiological regulation of NEFA availability: lipolysis pathway. Proc Nutr Soc 63: 369-374.
83. Mazloom Z, Ekramzadeh M, Hejazi N. 2013. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial. Pak J Biol Sci 16: 1597-1600.
84. Rafighi Z, Shiva A, Arab S, Mohd Yousof R. 2013. Association of dietary vitamin C and E intake and antioxidant enzymes in type 2 diabetes mellitus patients. Glob J Health Sci 5: 183-187.
85. Carter P, Gray LJ, Talbot D, Morris DH, Khunti K, Davies MJ. 2013. Fruit and vegetable intake and the association with glucose parameters: a cross-sectional analysis of the Let's Prevent Diabetes Study. Eur J Clin Nutr 67: 12-17.
86. Dakhale GN, Chaudhari HV, Shrivastava M. 2011. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci 2011: 195271.
87. Levin BE. 1991. Spontaneous motor activity during the development and maintenance of diet-induced obesity in the rat. Physiol Behav 50: 573-581.
88. Levin BE, Richard D, Michel C, Servatius R. 2000. Differential stress responsivity in diet-induced obese and resistant rats. Am J Physiol Regul Integr Comp Physiol 279: R1357-1364.
89. Buwalda B, Blom WA, Koolhaas JM, van Dijk G. 2001. Behavioral and physiological responses to stress are affected by high-fat feeding in male rats. Physiol Behav 73: 371-377.
90. Soulis G, Papalexi E, Kittas C, Kitraki E. 2007. Early impact of a fat-enriched diet on behavioral responses of male and female rats. Behav Neurosci 121: 483-490.
91. White LK, Carpenter M, Block M, Basse-Tomusk A, Gardiner TW, Rebec GV. 1988. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism. Psychopharmacology (Berl) 94: 284-287.
92. Miquel M, Aguilar MA, Aragon CM. 1999. Ascorbic acid antagonizes ethanol-induced locomotor activity in the open-field. Pharmacol Biochem Behav 62: 361-366.
93. Sahraei H, Aliabadi AA, Zarrindast MR, Ghoshooni H, Nasiri A, Barzegari-Sorkheh AA, Yari M, Zardooz H, Hossein-Mardi L, Faraji N, Shams J. 2007. Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice. Eur J Pharmacol 560: 42-48.
94. Yudkin JS. 2007. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 39: 707-709.
95. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumie A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Clement K. 2005. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277-2286.
96. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D. 2004. Weight loss regulates inflammation- related genes in white adipose tissue of obese subjects. FASEB J 18: 1657-1669.
97. Shoelson SE, Lee J, Goldfine AB. 2006. Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
98. Robertson RP, Harmon J, Tran PO, Poitout V. 2004. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 (Suppl 1): S119-124.
99. Arrigoni O, De Tullio MC. 2002. Ascorbic acid: much more than just an antioxidant. Biochim Biophys Acta 1569: 1-9.
100. Bowie AG, O'Neill LA. 2000. Vitamin C inhibits NFkappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol 165: 7180-7188.
101. Carcamo JM, Pedraza A, Borquez-Ojeda O, Zhang B, Sanchez R, Golde DW. 2004. Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta. Mol Cell Biol 24: 6645-6652.
102. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. 2004. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 110: 1564-1571.
103. Trayhurn P, Wang B, Wood IS. 2008. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100: 227-235.
104. Ye J, Gao Z, Yin J, He Q. 2007. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293: E1118-1128.
105. Ye J. 2009. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes 33: 54-66.
106. Quintero P, Milagro FI, Campion J, Martinez JA. 2010. Impact of oxygen availability on body weight management. Med Hypotheses 74: 901-907.
107. Quintero P, Gonzalez-Muniesa P, Martinez JA. 2012. Influence of different oxygen supply on metabolic markers and gene response in murine adipocytes. J Biol Regul Homeost Agents 26: 379-388.
108. Quintero P, Gonzalez-Muniesa P, Garcia-Diaz DF, Martinez JA. 2012. Effects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes. J Physiol Biochem 68: 663-669.
109. Trayhurn P. 2013. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 93: 1-21.
110. Devi SA, Vani R, Subramanyam MV, Reddy SS, Jeevaratnam K. 2007. Intermittent hypobaric hypoxia-induced oxidative stress in rat erythrocytes: protective effects of vitamin E, vitamin C, and carnitine. Cell Biochem Funct 25: 221-231.
111. Kim SS, Yang HW, Kang HG, Lee HH, Lee HC, Ko DS, Gosden RG. 2004. Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatment. Fertil Steril 82: 679-685.
112. Guaiquil VH, Golde DW, Beckles DL, Mascareno EJ, Siddiqui MA. 2004. Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 37: 1419-1429.
113. Carcamo JM, Borquez-Ojeda O, Golde DW. 2002. Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood 99: 3205-3212.
114. Muellner MK, Schreier SM, Schmidbauer B, Moser M, Quehenberger P, Kapiotis S, Goldenberg H, Laggner H. 2010. Vitamin C inhibits NO-induced stabilization of HIF-1alpha in HUVECs. Free Radic Res 44: 783-791.
115. Qiao H, Li L, Qu ZC, May JM. 2009. Cobalt-induced oxidant stress in cultured endothelial cells: prevention by ascorbate in relation to HIF-1alpha. Biofactors 35: 306-313.